Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 493 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR FDA Approves Cabozantinib for Adults and Paediatric Patients 12 Years of... April 18, 2025 Deputy Spends His Days Off Teaching Life Skills To Young Boys... December 26, 2021 ‘A significant step forwards’ – treating patients with advanced biliary tract... March 30, 2021 Children with Acute Lymphoblastic Leukemia Can Skip Radiation to the Brain November 25, 2019 Load more HOT NEWS How I Navigated Being a Young Mom During Cancer: A Survivor’s... ASCO Annual Meeting 2023: Improving Patients’ Lives Through Collaboration, Research, and... Sacituzumab Govitecan Plus Pembrolizumab Demonstrate Encouraging Activity in Patients with mUC... Adjuvant Nivolumab Prolongs DFS in Patients with Resected Osophageal or Gastroesophageal...
